Article PDF
References
Adams JM, Cory S. Transgenic models of tumour development. Science 254:1161–1167, 1991.
Agoston DV, Bravo DT, Waschek JA. Expression of a chimeric VIP gene is targeted to the intestine in transgenic mice. J Neurosci Res 27:479–486, 1990.
Alpert S, Hanahan D, Teitelman G. Hybrid insulin genes reveal a developmental lineage for pancreatic endocrine cells and imply a relationship with neurons. Cell 53:295–308, 1988.
Baetscher M, Schmidt E, Shimizu A, Leder P, Fishman MC. SV40 T antigen transforms calcitonin cells of the thyroid but not CGRP-containing neurons in transgenic mice. Onco-gene 6:1133–1138, 1991.
Behringer RR, Mathews LS, Palmiter RD, Brinster RL. Dwarf mice produced by genetic ablation of growth hormone-expressing cells. Genes Dev 2:453–461, 1988.
Borrelli E, Heyman RA, Arias C, Sawchenko PE, Evans RM. Transgenic mice with induc-ible dwarfism. Nature 339:538–541, 1989.
Breitman ML, Clapoff S, Rossant J, Tsui L-C, Glode LM, Maxwell IH, Bernstein A. Genetic ablation: targeted expression of a toxin gene causes microphthalmia in transgenic mice. Science 238:1563–1565, 1987.
Burton FH, Hasel KW, Bloom FE, Sutcliffe JG. Pituitary hyperplasia and gigantism in mice caused by a cholera toxin transgene. Nature 350:74–77, 1991.
Capecchi MR. Altering the genome by homologous recombination. Science 244:1288–1292, 1989.
Chisaka O, Capecchi MR. Regionally restricted developmental defects resulting from targeted disruption of the mouse homeobox gene hox-1.5. Nature 350:473–479, 1991.
Cory S, Adams JM. Transgenic mice and oncogenes. Annu Rev Immunol 6:25–48, 1988.
Efrat S, Linde S, Kofod H, Spector D, Delannoy M, Grant S, Hanahan D, Baekkesov S. Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene. Proc Natl Acad Sci USA 85:9037–9041, 1988.
Efrat S, Teitelman G, Anwar M, Ruggiero D, Hanahan D. Glucagon gene regulatory region directs oncoprotein expression to neurons and pancreatic alpha cells. Neuron 1:605–613, 1988.
Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339:58–61, 1989.
Hammang JP, Baetge EE, Behringer RR, Brinster RL, Palmiter RD, Messing A. Immortalized retinal neurons derived from SV40 T-antigen-induced tumors in transgenic mice. Neuron 4:775–782,1990.
Hammer RE, Brinster RL, Rosenfeld MG, Evans RM, Mayo KE. Expression of human growth hormone-releasing factor in transgenic mice results in increased somatic growth. Nature 315:413–416, 1985.
Hanahan D. Heritable formation of pancreatic B-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 315:115–122, 1985.
Hanahan D. Transgenic mice as probes into complex systems. Science 246:1265–1275, 1989.
Hanahan D. Transgenic mouse models of self-tolerance and autoreactivity by the immune system. Annu Rev Cell Biol 6:493–537, 1990.
Herskowitz I. Functional inactivation of genes by dominant negative mutations. Nature 329:219–222, 1987.
Jaenisch R. Transgenic animals. Science 240: 1468–1474, 1988.
Langford KG, Shai S-Y, Howard TE, Kovacs MJ, Overbeek PA, Bernstein KE. Transgenic mice demonstrate a testis-specific promoter for angiotensin-converting enzyme. J Biol Chem 266:15559–15562, 1991.
Lee YC, Asa SL, Drucker DJ. Glucagon gene 5’-flanking sequences direct expression of SV40 large T antigen to the intestine producing carcinoma of the large bowel in transgenic mice. J Biol Chem 267:10705–10708, 1992.
Lipes MA, Eisenbarth GS. Transgenic mouse models of type I diabetes. Diabetes 39: 879–884, 1990.
Magnuson MA. Tissue-specific regulation of glucokinase gene expression. J Cell Biochem 48:115–121, 1992.
Mayo KE, Hammer RE, Swanson LW, Brin-ster RL, Rosenfeld MG, Evans RM. Dramatic pituitary hyperplasia in transgenic mice expressing a human growth hormone-releasing factor gene. Mol Endocrinol 2:606–612, 1988.
Palmiter RD, Behringer RR, Quaife CJ, Maxwell F, Maxwell IH, Brinster RL. Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene. Cell 50:435–443, 1987.
Palmiter RD, Brinster RL. Germ-line transformation of mice. Annu Rev Genet 20:465–499, 1986.
Palmiter RD, Brinster RL, Hammer RE, Trumbauer ME, Rosenfeld MG, Birnberg NC, Evans RM. Dramatic growth of mice that develop from eggs microinjected with metal-lothionein-growth hormone fusion genes. Nature 300:611–615, 1982.
Rindi G, Grant SGN, Yiangou Y, Ghatei MA, Bloom SR, Bautch VL, Solcia E, Polak JM. Development of neuroendocrine tumors in the gastrointestinal tract of transgenic mice. Am J Pathol 136:1349–1363, 1990.
Roth KA, Gordon J I. Spatial differentiation of the intestinal epithelium: analysis of enteroen-docrine cells containing immunoreactive serotonin, secretin, and substance P in normal and transgenic mice. Proc Natl Acad Sci USA 87:6408–6412, 1990.
Stefaneanu L, Kovacs K, Horvath E, Asa SL, Losinski NE, Billestrup N, Price J, Vale W. Adenohypophyseal changes in mice transgenic for human growth hormone-releasing factor: histological, immunocytochemical, and electron microscopic investigation. Endocrinology 125:2710–2718, 1989.
Struthers RS, Vale W, Arias C, Sawchenko PE, Montminy MR. Somatotroph hypoplasia and dwarfism in transgenic mice expressing a non-phosphorylatable CREB mutant. Nature 350:622–624, 1991.
Teitelman G, Alpert S, Hanahan D. Proliferation, senescence and neoplastic progression of beta cells in hyperplasic pancreatic islets. Cell 52:97–105, 1988.
Wallace H, Ledent C, Vassart G, Bishop JO, Al-Shawi R. Specific ablation of thyroid follicle cells in adult transgenic mice. Endocrinology 129:3217–3226, 1991.
Windle JJ, Albert DM, O’Brien JM, Marcus DM, Disteche CM, Bernards R, Mellon PL. Retinoblastoma in transgenic mice. Nature 343:665–669, 1990.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Campos, R.V., Drucker, D.J. Transgenic mice in the study of endocrine systems. Endocr Pathol 3, 111–115 (1992). https://doi.org/10.1007/BF02921351
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02921351